Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPEC.L Regulatory News (JPEC)

  • There is currently no data for JPEC

Directorate Change

7 Oct 2020 09:08

RNS Number : 3635B
JPMorgan Elect PLC
07 October 2020
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN ELECT PLC

 

("the Company")

 

NEW DIRECTOR APPOINTMENT (LR 9.6.11 and 9.6.13)

 

 

Legal Entity Identifier: 549300FIUYKKL39ILD07

Information disclosed in accordance with LR 9.6.11 and LR 9.6.13

The Board of JPMorgan Elect Plc is pleased to announce the appointment of Mrs. Davina Walter and Mr. Steve Bates as Non-Executive Directors of the Company with effect from 15th October 2020.

Mrs. Walter is currently engaged as an investment consultant having started her career at Cazenove & Co where she spent more than 11 years involved in US equity research. She spent over 16 years as an investment manager of US equity portfolios, most recently as a Managing Director at Deutsche Asset Management. She has been actively involved with investment trusts since 1985 and is currently Chairman and a director of Aberdeen Diversified Income & Growth Trust plc. 

 

Mr. Steve Bates is currently serving as Director and Chief Investment Officer of GuardCap Asset Management Limited and is also a Director of GuardCap UCITS plc and Biotech Growth Trust plc. He has served as the head of emerging markets at JP Morgan Fleming Asset Management, a business he established for predecessor organization (Flemings) in 1990. Steve is non-executive Chairman of Vinacapital Vietnam Opportunity Fund Limited and of Third Point Offshore Investors Limited.

 

Commenting on the proposed appointment Mr. Alan Hodson, Chairman of the Company stated:

 

"I am delighted that Davina and Steve are joining the Board of JPMorgan Elect plc. They bring a significant range of corporate and strategic knowledge and perspective to the Board. I am confident that both Davina and Steve will be excellent additions."

 

Mrs. Walter holds 1,500 Managed Growth shares and 3,500 Managed Income shares in the Company.

 

Mr. Bates holds 250,596 Managed Growth shares in the Company.

 

There are no other disclosures required to be made for the appointments in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

07 October 2020

For further information, please contact:

 

Priyanka Vijay Anand

JPMorgan Funds Limited

Company Secretary

 

Telephone 0207 742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGIBDGUGGDGGR
Date   Source Headline
21st Sep 20224:37 pmRNSTransaction in Own Shares
21st Sep 202210:57 amRNSNet Asset Value(s)
20th Sep 202212:16 pmRNSGearing announcement
20th Sep 202211:43 amRNSNet Asset Value(s)
16th Sep 20224:13 pmRNSTen Largest Investments
16th Sep 202211:22 amRNSNet Asset Value(s)
15th Sep 202211:05 amRNSNet Asset Value(s)
14th Sep 202212:35 pmRNSNet Asset Value(s)
13th Sep 20225:08 pmRNSTransaction in Own Shares
13th Sep 202210:51 amRNSNet Asset Value(s)
12th Sep 20224:40 pmRNSChange in Dividend Payment Date
12th Sep 202211:51 amRNSGearing Announcement
12th Sep 202211:15 amRNSNet Asset Value(s)
9th Sep 202211:31 amRNSNet Asset Value(s)
8th Sep 202210:48 amRNSNet Asset Value(s)
7th Sep 20224:56 pmRNSTransaction in Own Shares
7th Sep 202211:01 amRNSNet Asset Value(s)
6th Sep 202212:48 pmRNSGearing Announcement
6th Sep 202210:54 amRNSNet Asset Value(s)
5th Sep 202211:24 amRNSNet Asset Value(s)
2nd Sep 202211:39 amRNSNet Asset Value(s)
1st Sep 20222:27 pmRNSClosed Period Notification
1st Sep 202212:14 pmRNSNet Asset Value(s)
1st Sep 202210:56 amRNSTotal Voting Rights
31st Aug 202211:01 amRNSNet Asset Value(s)
30th Aug 20225:21 pmRNSTransaction in Own Shares
30th Aug 20222:58 pmRNSGearing Announcement
30th Aug 20221:55 pmRNSNet Asset Value(s)
30th Aug 202210:59 amRNSChange in Nominal Value
26th Aug 20223:06 pmRNSTransaction in Own Shares
26th Aug 202211:39 amRNSNet Asset Value(s)
25th Aug 20225:49 pmRNSTransaction in Own Shares
25th Aug 202210:53 amRNSNet Asset Value(s)
24th Aug 20223:38 pmRNSConversion of Securities
24th Aug 202210:41 amRNSNet Asset Value(s)
23rd Aug 202211:25 amRNSNet Asset Value(s)
22nd Aug 202212:28 pmRNSGearing announcement
22nd Aug 202211:21 amRNSNet Asset Value(s)
19th Aug 202211:20 amRNSNet Asset Value(s)
18th Aug 202211:16 amRNSNet Asset Value(s)
17th Aug 202212:12 pmRNSNet Asset Value(s)
16th Aug 202211:00 amRNSNet Asset Value(s)
15th Aug 20224:25 pmRNSTransaction in Own Shares
15th Aug 202211:56 amRNSGearing announcement
15th Aug 202210:52 amRNSNet Asset Value(s)
12th Aug 20224:37 pmRNSTen Largest Investments
12th Aug 20224:01 pmRNSTransaction in Own Shares
12th Aug 202211:17 amRNSNet Asset Value(s)
11th Aug 202210:36 amRNSNet Asset Value(s)
10th Aug 202211:26 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.